Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?
Abstract Limited drug delivery to the brain is one of the major reasons for high failure rates of central nervous system (CNS) drug candidates. The blood–brain barrier (BBB) with its tight junctions, membrane transporters, receptors and metabolizing enzymes is a main player in drug delivery to the b...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Revisão |
| Hizkuntza: | ingelesa |
| Argitaratua: |
2022
|
| Sarrera elektronikoa: | https://doi.org/10.1007/s11095-022-03241-x https://link.springer.com/content/pdf/10.1007/s11095-022-03241-x.pdf |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|